BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2012
View Archived Issues
Clinical results presented for the RTS,S/AS01 malaria vaccine
Read More
Novel pegylated camptothecin derivatives disclosed by Chinese researchers
Read More
Stanford University creates novel peptide therapeutics for leishmaniasis and trypanosomiasis
Read More
Pfizer reports topline results from phase III pregabalin trial in epilepsy
Read More
JCR's phase II/III stem cell trial completes enrollment
Read More
Xenetic reports phase I/IIa MS vaccine trial initiation in Russia
Read More
Incyte and Lilly present promising phase II data for baricitinib in rheumatoid arthritis
Read More
Novel 3D neuroblastoma-based in vitro culture model designed to investigate tauopathies
Read More
Researchers publish results of first-in-human trial of APR-246
Read More
Novel mGlu5 receptor modulators disclosed by Roche
Read More
New vaccines for birch pollen allergy presented by Teknologian Tutkimuskeskus
Read More
Santaris Pharma prepares novel antisense oligonucleotides
Read More
Bayer patents new TTK inhibitors
Read More
NeuroSearch designs new modulators of neurotransmission
Read More
CHMP recommends Exjade approval for non-transfusion-dependent thalassemia syndromes
Read More
Zytiga receives positive CHMP recommendation for castration-resistant prostate cancer
Read More
Brd1 gene knockout produces schizophrenia and depression phenotypes
Read More
Pluristem begins phase I/II trial of PLX cells in muscle injury
Read More
Amgen describes novel peptide agonist of the CaS receptor
Read More
Alexza Pharmaceuticals receives updated list of outstanding issues for Adasuve
Read More
Sobi files MAA to expand Kineret label
Read More
GlaxoSmithKline receives new FDA approval for Promacta
Read More
CFFT and Pfizer expand drug discovery collaboration
Read More
UCB begins phase III lacosamide study in Asia
Read More
FDA grants fast track status to OBI-1 for acquired hemophilia A
Read More